To present evolving concepts and advancements in the diagnosis of parathyroid diseases, emphasizing their clinical significance.
Approach:
Key Findings:
FCH PET/CT outperforms MIBI SPECT/CT in localization and postoperative outcomes, enhancing surgical success.
Dynamic biomarker profiling can enhance risk stratification in PHPT, leading to tailored treatment.
Predictive models can improve management of phosphorus levels post-TPTx, aiding in patient care.
Inflammatory markers may indicate disease activity and complication risk in PHPT, providing additional diagnostic insights.
3D anatomical models improve surgical planning and patient understanding, facilitating better surgical outcomes.
Combined calcium–chloride/phosphorus ratio is effective for early PHPT screening, allowing for timely intervention.
Interpretation:
The editorial emphasizes a shift towards a more integrated and personalized approach in diagnosing and managing parathyroid disorders, highlighting the potential for improved patient outcomes.
Conclusion:
The advancements in diagnostic techniques and biomarker profiling represent a paradigm shift in the management of parathyroid diseases, with significant implications for patient care.
